Health Canada seeks your input on openness and transparency
Printer-friendly version
Questions on Openness and Transparency to Key Stakeholders
Health Canada’s therapeutic health product vigilance program is seeking to identify possible areas of improvement with regards to the openness and transparency of health product vigilance. This topic will be addressed at the upcoming meeting of the Expert Advisory Committee on the Vigilance of Health Products (EAC-VHP) to be held in Ottawa, Ontario, October 24-25, 2012.
In support of this activity, Health Canada’s Health Products and Food Branch (HPFB) is inviting you to provide your input on this very important topic by responding to the two questions found below.
Please submit your input via email to EAC-VHP_CCE-VPS@hc-sc.gc.ca or by mail to:
Expert Advisory Committee on the Vigilance of Health Products (EAC-VHP) Secretariat
Health Canada
200 Tunney’s Pasture Driveway,
Address Locator 0700B
Ottawa, Ontario
K1A 0K9
Alternatively, to request to present your input in person at the EAC-VHP meeting on October 24, 2012 or to observe the committee proceedings, please complete and return the attached form. Each presentation will be limited to 15 minutes. Travel and hospitality expenses will not be covered by Health Canada.
Input and requests to present must be received by the Secretariat on or before September 14th, 2012, close of business.
You are invited to forward information about this opportunity and the upcoming EAC-VHP meeting to your membership, affiliated networks or any additional associations you feel may be interested.
Questions on Openness and Transparency
1. What are your experiences regarding the openness and transparency of Health Canada’s therapeutic health product vigilance program for marketed health products ?
2. Have you ever looked for information on marketed health products on the Health Canada website and not been able to find it? If so, what type of information were you unable to find?
Openness is inviting, hearing, considering and sharing of information in the conduct of HPFB's business.
Transparency is facilitating access to and understanding of the information and processes HPFB uses to conduct its business.
Therapeutic health product vigilance is a term used for setting the standards and monitoring the safety, efficacy and quality of all health products available for sale in Canada.
Marketed health product is a pharmaceutical, biologic, medical device or natural health product that is marketed in Canada.
The EAC-VHP Secretariat looks forward to hearing from you.
EAC-VHP Secretariat / Secrétariat CCE-VPS
Dara Hakimzadeh - Policy Analyst / Analyste de politiques, 613-941-0251
Dobrila Todoric - Policy Stakeholder Relations Analyst / Analyste de politiques sur les relations avec les intervenants, 613-960-6073
Poonam Sood - Secretariat Officer, Agente de secrétariat
Room 0198- 200 Tunney's Pasture Driveway
Tunney's Pasture, Ottawa, Ontario, K1A 0K9
A.L. 0700B
Fax: 613-960-8229
| Attachment | Size |
|---|---|
| Fill-in Form for SH.docx | 11.11 KB |
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.